Figure 2
Figure 2. Elevated levels of ROS in the most primitive LSCs from CML-CP–like mice. BMCs were obtained from healthy (black bars) and CML-CP–like (gray bars) mice. (A) ROS were detected with DCFDA in HSCs/LSCs (Lin−c-Kit+Sca-1+) and HPCs/LPCs (Lin−c-Kit+Sca-1−) from 7 healthy (black bars) and 4 CML-CP–like (gray bars) animals. *P ≤ .001 in comparison with HSCs; and P < .05 in comparison with LPCs. (B) ROS were detected with DCFDA in BM-derived subpopulations of Lin−c-Kit+Sca-1+ cells from 2 healthy and 2 CML-CP–like mice: CD34−Flt3− LT, CD34+Flt3− ST, and CD34+Flt3+ MPPs. *P < .05 in comparison with healthy counterparts. (C) ROS were measured with DHE (left panel) and CC-1 (right panel) in Lin−c-Kit+Sca-1+CFSEmax quiescent cells from 7 and 4 normal, and 3 and 3 CML-CP–like mice, respectively. *P < .05 and **P < .005 in comparison with healthy counterparts.

Elevated levels of ROS in the most primitive LSCs from CML-CP–like mice. BMCs were obtained from healthy (black bars) and CML-CP–like (gray bars) mice. (A) ROS were detected with DCFDA in HSCs/LSCs (Linc-Kit+Sca-1+) and HPCs/LPCs (Linc-Kit+Sca-1) from 7 healthy (black bars) and 4 CML-CP–like (gray bars) animals. *P ≤ .001 in comparison with HSCs; and P < .05 in comparison with LPCs. (B) ROS were detected with DCFDA in BM-derived subpopulations of Linc-Kit+Sca-1+ cells from 2 healthy and 2 CML-CP–like mice: CD34Flt3 LT, CD34+Flt3 ST, and CD34+Flt3+ MPPs. *P < .05 in comparison with healthy counterparts. (C) ROS were measured with DHE (left panel) and CC-1 (right panel) in Linc-Kit+Sca-1+CFSEmax quiescent cells from 7 and 4 normal, and 3 and 3 CML-CP–like mice, respectively. *P < .05 and **P < .005 in comparison with healthy counterparts.

Close Modal

or Create an Account

Close Modal
Close Modal